WPD Pharmaceuticals Inc. (CSE:WBIO)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
At close: May 8, 2025
WPD Pharmaceuticals Company Description
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of biological compounds and small molecules. The company is headquartered in Vancouver, Canada.
WPD Pharmaceuticals Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Mariusz Olejniczak |
Contact Details
Address: 750 West Pender Street, Vancouver, BC V6C 2T7 Canada | |
| Website | wpdpharmaceuticals.com |
Stock Details
| Ticker Symbol | WBIO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA92941F2044 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Katarzyna Suchoszek Ph.D. | Director f Operations |
| Beata Pajak Eng., Ph.D. | Chief Scientific Officer |
| Marek Sipowicz M.D., Ph.D. | Chief Medical Officer |